ABOUT THE SERVICE
Lantern Pharma’s proprietary RADR platform utilizes artificial intelligence and machine learning to rapidly analyze genomic data and patient populations, providing critical insights for drug development and patient stratification. This platform is instrumental in our efforts to rescue and revitalize abandoned cancer drugs and identify new treatment opportunities.
Information is owner-confirmed
Last updated 4 months ago
Price range